Arrowhead Shares Surge with $825 Million Sarepta Therapeutics Deal
Daily NewsOn Tuesday, shares of Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) rose 32% following the announcement of a comprehensive licensing and collaboration agreement wi...
Read More